Trial intelligence / Profile preview

Linezolid for Penicillin-Resistant Streptococcus Pneumoniae Pneumonia

NCT00035269Phase 3Completed

Sponsor
Pfizer
Start
Dec 2001
Modality
Small Molecules
Countries
4
01

Overview

A Phase 3 trial of linezolid in Pneumococcal pneumonia (PP), sponsored by Pfizer. Started Dec 2001; status: completed.

02

Drugs

linezolid
03

Conditions

Pneumococcal pneumonia (PP)

Beyond the preview

Go deeper on NCT00035269.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00035269.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call